Nixon Paul, Butt Warwick
Intensive Care Unit, Alfred Hospital, Melbourne, VIC, Australia.
School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australia.
Perfusion. 2021 Sep;36(6):573-574. doi: 10.1177/0267659120986760. Epub 2021 Jan 7.
COVID results in a variety of pathophysiology that causes cardiorespiratory and the need for ECMO. These include hypoxic respiratory failure, cardiogenic shock, cardiac arrest, multisystem inflammatory disease, and vascular thrombosis with pulmonary embolism. A variety of cannulation strategies are required and the "hyperinflammation" and consequent coagulation abnormalities mandate new strategies to provide optimal ECMO support.
新冠病毒感染会导致多种病理生理状况，引发心肺问题并需要体外膜肺氧合（ECMO）支持。这些状况包括低氧性呼吸衰竭、心源性休克、心脏骤停、多系统炎症性疾病以及伴有肺栓塞的血管血栓形成。需要采用多种插管策略，而“炎症风暴”及随之而来的凝血异常要求采取新策略以提供最佳的ECMO支持。
